News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News 06 mar 2023 Mindmaze launches revolutionary device to improve hand recovery after stroke MindMaze, a Vaud-based worldwide leader in AI-powered digital neurotherapeutics, has released its own proprietary medical device called Izar in t...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 23 nov 2023 biped.ai secures CHF 1.2 million for US expansion and European growth Lausanne-based start-up biped.ai, known for its revolutionary technology aiding the visually impaired, has successfully raised CHF 1.2 million.
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 30 set 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
News 03 nov 2021 USD 17.5 million for Aktiia’s 24/7 blood pressure monitor Neuchâtel-based health tech start-up Aktiia raised USD 17.5 million in a Series A funding round led by Draper Esprit.
News 13 abr 2021 Lonza to create 1,200 new jobs at its Covid-19 vaccine production site in Visp Biopharmaceutical giant Lonza has announced the creation of 1,200 new jobs for the manufacturing of Moderna’s Covid-19 vaccine on its site in Vis...
Global Opportunities 03 jun 2020 The Pharmaceutical Sector in Ireland: Opportunities for Swiss companies As cornerstones of the Irish economy, the pharma and life sciences sectors have contributed vastly to the attractiveness of Ireland to foreign co...
Global Opportunities 10 dez 2020 What you need to know about the Irish Healthcare Sector Ireland shows true commitment to public healthcare with the majority of its population entitled to free medical care. Yet this brings about many ...